BioCentury | Oct 24, 2020
Translation in Brief

UNC Chapel Hill Angelman gene therapy rescues motor function; plus data backing planned Pacylex, Kronos clinical trials and more

...– MicroRNA-132SNORD115 (HBII-52) – Small nucleolar RNA, C/D Box 115UBE3A (E6AP) – Ubiquitin protein ligase E3A Danielle Golovin PCLX-001 KB-0742 University of North Carolina at Chapel Hill Asklepios...
BioCentury | Aug 29, 2020
Product Development

COVID-19 Quick Takes: FDA expands remdesivir EUA; plus Warp Speed, Abbott, Moderna-Japan, CanSino-Canada, BeiGene-Singlomics, Sinovac, UNC, Daiichi, Laurent

...since July 22.Modeling COVID-19 disease, treatment with mouse-adapted SARS-CoV-2A team led by Ralph Baric at University of North Carolina at Chapel Hill...
...Staff Veklury, remdesivir (GS-5734) Eiger BioPharmaceuticals Inc. Gilead Sciences Inc. BioNTech SE Pfizer Inc. Moderna Inc. Abbott Laboratories CanSino Biologics Inc. BeiGene Ltd. Sinovac Biotech Ltd. University of North Carolina at Chapel Hill Daiichi...
BioCentury | Aug 1, 2020
Translation in Brief

TScan identifies CD8+ T cell COVID-19 epitopes, plus T3 gears up for Phase I of bacterial cancer therapy, a wearable device to monitor PK and a COVID-19 vaccine

...egg production In a bioRxiv publication , Icahn School of Medicine at Mount Sinai and University of North Carolina at Chapel Hill...
...SARS-CoV-2 spike protein d Danielle Golovin, Staff Writer TScan Therapeutics Inc. Icahn School of Medicine at Mount Sinai University of North Carolina at Chapel Hill Stanford...
BioCentury | Jul 8, 2020
Product Development

NIH, Warp Speed streamline preventive mAb, vaccine testing via clinical trial network

...by Myron Cohen, director of the Institute for Global Health & Infectious Diseases at the University of North Carolina...
BioCentury | Jun 4, 2020
Product Development

WHO restarts hydroxychloroquine testing as drug fails another COVID-19 trial

...clinical organizations to support data analysis. At least 15 institutions including Johns Hopkins University, the University of North Carolina at Chapel Hill...
BioCentury | Apr 30, 2020
Distillery Therapeutics

Heparan sulfate for prevention of acetaminophen-induced acute liver failure

...et al. Sci. Transl. Med. ; published online March 18, 2020 doi:10.1126/scitranslmed.aav8075 CONTACT: Jian Liu, University of North Carolina at Chapel Hill...
...Chapel Hill, N.C. email: jian_liu@unc.edu CONTACT: Ding Xu, University at Buffalo, Buffalo, N.Y. email: dingxu@buffalo.edu Claire Quang University of North Carolina at Chapel Hill University...
BioCentury | Apr 8, 2020
Deals

COVID-19 roundup: U.S. to freeze WHO funding as Wellcome calls on CEOs to support $8B fund; plus Ridgeback-Emory, Karyopharm, IQVia and more

...which Ridgeback exclusively licensed from the non-profit in March, is an oral prodrug of EIDD-1931. University of North Carolina...
BioCentury | Apr 7, 2020
Product Development

COVID-19 roundup: Inovio starts vaccine trial; plus updates from RedHill, Hope, CytoDyn, Gilead, Takeda, AACR and UNC-Emory

...96 samples in about four hours. UNC data for Emory compound A team lead by University of North Carolina...
BioCentury | Mar 26, 2020
Emerging Company Profile

ReCode: merging RNA therapies and organ-specific delivery for respiratory diseases

...Founded: 2020 by Leon Chen, David Lockhart, Daniel Siegwart, Philip Thomas, Michael Torres University collaborators: University of North Carolina...
BioCentury | Feb 29, 2020
Translation in Brief

Genentech finds non-exhausted antitumor T cell source in blood, plus updates on Penn and Chordoma Foundation-Mark Foundation

...a three-university team to create small molecules inhibiting TBXT to treat chordoma. David Drewry at University of North Carolina at Chapel Hill...
Items per page:
1 - 10 of 370
BioCentury | Oct 24, 2020
Translation in Brief

UNC Chapel Hill Angelman gene therapy rescues motor function; plus data backing planned Pacylex, Kronos clinical trials and more

...– MicroRNA-132SNORD115 (HBII-52) – Small nucleolar RNA, C/D Box 115UBE3A (E6AP) – Ubiquitin protein ligase E3A Danielle Golovin PCLX-001 KB-0742 University of North Carolina at Chapel Hill Asklepios...
BioCentury | Aug 29, 2020
Product Development

COVID-19 Quick Takes: FDA expands remdesivir EUA; plus Warp Speed, Abbott, Moderna-Japan, CanSino-Canada, BeiGene-Singlomics, Sinovac, UNC, Daiichi, Laurent

...since July 22.Modeling COVID-19 disease, treatment with mouse-adapted SARS-CoV-2A team led by Ralph Baric at University of North Carolina at Chapel Hill...
...Staff Veklury, remdesivir (GS-5734) Eiger BioPharmaceuticals Inc. Gilead Sciences Inc. BioNTech SE Pfizer Inc. Moderna Inc. Abbott Laboratories CanSino Biologics Inc. BeiGene Ltd. Sinovac Biotech Ltd. University of North Carolina at Chapel Hill Daiichi...
BioCentury | Aug 1, 2020
Translation in Brief

TScan identifies CD8+ T cell COVID-19 epitopes, plus T3 gears up for Phase I of bacterial cancer therapy, a wearable device to monitor PK and a COVID-19 vaccine

...egg production In a bioRxiv publication , Icahn School of Medicine at Mount Sinai and University of North Carolina at Chapel Hill...
...SARS-CoV-2 spike protein d Danielle Golovin, Staff Writer TScan Therapeutics Inc. Icahn School of Medicine at Mount Sinai University of North Carolina at Chapel Hill Stanford...
BioCentury | Jul 8, 2020
Product Development

NIH, Warp Speed streamline preventive mAb, vaccine testing via clinical trial network

...by Myron Cohen, director of the Institute for Global Health & Infectious Diseases at the University of North Carolina...
BioCentury | Jun 4, 2020
Product Development

WHO restarts hydroxychloroquine testing as drug fails another COVID-19 trial

...clinical organizations to support data analysis. At least 15 institutions including Johns Hopkins University, the University of North Carolina at Chapel Hill...
BioCentury | Apr 30, 2020
Distillery Therapeutics

Heparan sulfate for prevention of acetaminophen-induced acute liver failure

...et al. Sci. Transl. Med. ; published online March 18, 2020 doi:10.1126/scitranslmed.aav8075 CONTACT: Jian Liu, University of North Carolina at Chapel Hill...
...Chapel Hill, N.C. email: jian_liu@unc.edu CONTACT: Ding Xu, University at Buffalo, Buffalo, N.Y. email: dingxu@buffalo.edu Claire Quang University of North Carolina at Chapel Hill University...
BioCentury | Apr 8, 2020
Deals

COVID-19 roundup: U.S. to freeze WHO funding as Wellcome calls on CEOs to support $8B fund; plus Ridgeback-Emory, Karyopharm, IQVia and more

...which Ridgeback exclusively licensed from the non-profit in March, is an oral prodrug of EIDD-1931. University of North Carolina...
BioCentury | Apr 7, 2020
Product Development

COVID-19 roundup: Inovio starts vaccine trial; plus updates from RedHill, Hope, CytoDyn, Gilead, Takeda, AACR and UNC-Emory

...96 samples in about four hours. UNC data for Emory compound A team lead by University of North Carolina...
BioCentury | Mar 26, 2020
Emerging Company Profile

ReCode: merging RNA therapies and organ-specific delivery for respiratory diseases

...Founded: 2020 by Leon Chen, David Lockhart, Daniel Siegwart, Philip Thomas, Michael Torres University collaborators: University of North Carolina...
BioCentury | Feb 29, 2020
Translation in Brief

Genentech finds non-exhausted antitumor T cell source in blood, plus updates on Penn and Chordoma Foundation-Mark Foundation

...a three-university team to create small molecules inhibiting TBXT to treat chordoma. David Drewry at University of North Carolina at Chapel Hill...
Items per page:
1 - 10 of 370